Latest Immunohistochemistry Stories
The patented technology, now protected in both Europe and in the United States, enables perfect alignment of whole slide images at any magnification, independently of tissue type and staining.
The feasibility of selecting treatment based on individual molecular characteristics was demonstrated in a first-of-its kind pancreatic cancer clinical trial reported today by the Translational Genomics Research Institute (TGen) and the Virginia G. Piper Cancer Center at Scottsdale Healthcare.
AMIRSYS, INC. announced today the update of its PathIQ ImmunoQuery product for pathologists. Salt Lake City, UT (PRWEB) March 18, 2012 AMIRSYS, INC.
Visiopharm’s rapidly expands the APPCenter and showcases over 30 APPs for cancer research, diabetes, neuroscience, respiratory and much more.
- A volcanic mudflow.